450 related articles for article (PubMed ID: 25744568)
21. Streptozotocin Intracerebroventricular-Induced Neurotoxicity and Brain Insulin Resistance: a Therapeutic Intervention for Treatment of Sporadic Alzheimer's Disease (sAD)-Like Pathology.
Kamat PK; Kalani A; Rai S; Tota SK; Kumar A; Ahmad AS
Mol Neurobiol; 2016 Sep; 53(7):4548-62. PubMed ID: 26298663
[TBL] [Abstract][Full Text] [Related]
22. Sodium orthovanadate improves learning and memory in intracerebroventricular-streptozotocin rat model of Alzheimer's disease through modulation of brain insulin resistance induced tau pathology.
Akhtar A; Bishnoi M; Sah SP
Brain Res Bull; 2020 Nov; 164():83-97. PubMed ID: 32784004
[TBL] [Abstract][Full Text] [Related]
23. Disbalance of the Duodenal Epithelial Cell Turnover and Apoptosis Accompanies Insensitivity of Intestinal Redox Homeostasis to Inhibition of the Brain Glucose-Dependent Insulinotropic Polypeptide Receptors in a Rat Model of Sporadic Alzheimer's Disease.
Homolak J; Babic Perhoc A; Knezovic A; Osmanovic Barilar J; Koc F; Stanton C; Ross RP; Salkovic-Petrisic M
Neuroendocrinology; 2022; 112(8):744-762. PubMed ID: 34607331
[TBL] [Abstract][Full Text] [Related]
24. Involvement of glucose related energy crisis and endoplasmic reticulum stress: Insinuation of streptozotocin induced Alzheimer's like pathology.
Biswas J; Gupta S; Verma DK; Gupta P; Singh A; Tiwari S; Goswami P; Sharma S; Singh S
Cell Signal; 2018 Jan; 42():211-226. PubMed ID: 29126976
[TBL] [Abstract][Full Text] [Related]
25. Synchronous nonmonotonic changes in functional connectivity and white matter integrity in a rat model of sporadic Alzheimer's disease.
Tristão Pereira C; Diao Y; Yin T; da Silva AR; Lanz B; Pierzchala K; Poitry-Yamate C; Jelescu IO
Neuroimage; 2021 Jan; 225():117498. PubMed ID: 33164858
[TBL] [Abstract][Full Text] [Related]
26. Central cholinergic function and metabolic changes in streptozotocin-induced rat brain injury.
Yuliani T; Lobentanzer S; Klein J
J Neurochem; 2021 Sep; 158(6):1307-1319. PubMed ID: 33448390
[TBL] [Abstract][Full Text] [Related]
27. Enhancement of β-amyloid oligomer accumulation after intracerebroventricular injection of streptozotocin, which involves central insulin signaling in a transgenic mouse model.
Lin F; Jia J; Qin W
Neuroreport; 2014 Nov; 25(16):1289-95. PubMed ID: 25202927
[TBL] [Abstract][Full Text] [Related]
28. AMPK activation ameliorates Alzheimer's disease-like pathology and spatial memory impairment in a streptozotocin-induced Alzheimer's disease model in rats.
Du LL; Chai DM; Zhao LN; Li XH; Zhang FC; Zhang HB; Liu LB; Wu K; Liu R; Wang JZ; Zhou XW
J Alzheimers Dis; 2015; 43(3):775-84. PubMed ID: 25114075
[TBL] [Abstract][Full Text] [Related]
29. From Determining Brain Insulin Resistance in a Sporadic Alzheimer's Disease Model to Exploring the Region-Dependent Effect of Intranasal Insulin.
Knezovic A; Budisa S; Babic Perhoc A; Homolak J; Osmanovic Barilar J
Mol Neurobiol; 2023 Apr; 60(4):2005-2023. PubMed ID: 36596966
[TBL] [Abstract][Full Text] [Related]
30. Antioxidative and Neuroprotective Effects of Curcumin in an Alzheimer's Disease Rat Model Co-Treated with Intracerebroventricular Streptozotocin and Subcutaneous D-Galactose.
Huang HC; Zheng BW; Guo Y; Zhao J; Zhao JY; Ma XW; Jiang ZF
J Alzheimers Dis; 2016 Apr; 52(3):899-911. PubMed ID: 27060945
[TBL] [Abstract][Full Text] [Related]
31. Streptozotocin-induced sporadic Alzheimer's disease: selection of appropriate dose.
Mehla J; Pahuja M; Gupta YK
J Alzheimers Dis; 2013; 33(1):17-21. PubMed ID: 22886014
[TBL] [Abstract][Full Text] [Related]
32. Formyl Peptide Receptor 2 Deficiency Improves Cognition and Attenuates Tau Hyperphosphorylation and Astrogliosis in a Mouse Model of Alzheimer's Disease.
Zhang H; Wang D; Gong P; Lin A; Zhang Y; Ye RD; Yu Y
J Alzheimers Dis; 2019; 67(1):169-179. PubMed ID: 30475772
[TBL] [Abstract][Full Text] [Related]
33. Early and Persistent O-GlcNAc Protein Modification in the Streptozotocin Model of Alzheimer's Disease.
Dos Santos JPA; Vizuete A; Hansen F; Biasibetti R; Gonçalves CA
J Alzheimers Dis; 2018; 61(1):237-249. PubMed ID: 29154269
[TBL] [Abstract][Full Text] [Related]
34. Intracerebroventricular streptozotocin impairs adult neurogenesis and cognitive functions via regulating neuroinflammation and insulin signaling in adult rats.
Mishra SK; Singh S; Shukla S; Shukla R
Neurochem Int; 2018 Feb; 113():56-68. PubMed ID: 29174383
[TBL] [Abstract][Full Text] [Related]
35. Reduced brain antioxidant capacity in rat models of betacytotoxic-induced experimental sporadic Alzheimer's disease and diabetes mellitus.
Tahirovic I; Sofic E; Sapcanin A; Gavrankapetanovic I; Bach-Rojecky L; Salkovic-Petrisic M; Lackovic Z; Hoyer S; Riederer P
Neurochem Res; 2007 Oct; 32(10):1709-17. PubMed ID: 17605105
[TBL] [Abstract][Full Text] [Related]
36. Audiogenic Seizures in the Streptozotocin-Induced Rat Alzheimer's Disease Model.
Alves SS; de Oliveira JAC; Lazarini-Lopes W; Servilha-Menezes G; Grigório-de-Sant'Ana M; Del Vecchio F; Mazzei RF; Sousa Almeida S; da Silva Junior RMP; Garcia-Cairasco N
J Alzheimers Dis; 2023; 94(3):1179-1196. PubMed ID: 37393501
[TBL] [Abstract][Full Text] [Related]
37. 7,8-Dihydroxyflavone improves cognitive functions in ICV-STZ rat model of sporadic Alzheimer's disease by reversing oxidative stress, mitochondrial dysfunction, and insulin resistance.
Akhtar A; Dhaliwal J; Sah SP
Psychopharmacology (Berl); 2021 Jul; 238(7):1991-2009. PubMed ID: 33774703
[TBL] [Abstract][Full Text] [Related]
38. Central insulin resistance as a trigger for sporadic Alzheimer-like pathology: an experimental approach.
Salkovic-Petrisic M; Hoyer S
J Neural Transm Suppl; 2007; (72):217-33. PubMed ID: 17982898
[TBL] [Abstract][Full Text] [Related]
39. Tau Cleavage Contributes to Cognitive Dysfunction in Strepto-Zotocin-Induced Sporadic Alzheimer's Disease (sAD) Mouse Model.
Latina V; Giacovazzo G; Calissano P; Atlante A; La Regina F; Malerba F; Dell'Aquila M; Stigliano E; Balzamino BO; Micera A; Coccurello R; Amadoro G
Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830036
[TBL] [Abstract][Full Text] [Related]
40. Brain antioxidant capacity in rat models of betacytotoxic-induced experimental sporadic Alzheimer's disease and diabetes mellitus.
Tahirovic I; Sofic E; Sapcanin A; Gavrankapetanovic I; Bach-Rojecky L; Salkovic-Petrisic M; Lackovic Z; Hoyer S; Riederer P
J Neural Transm Suppl; 2007; (72):235-40. PubMed ID: 17982899
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
